Literature DB >> 14512724

Prediction of the rate of decline in cognitive function in Alzheimer's disease: a model based on simple demographic data and widely used rating scales.

Sigurd Johnsen1, Steve Hughes, Roger Bullock, Ian Hindmarch.   

Abstract

Dementia represents a significant burden on the resources of both the National Health Service and Social Services as well as a great strain on the caregivers. The ability to predict, at diagnosis, those dementia patients that will deteriorate rapidly would allow a more effective allocation of resources as well as enabling the families and caregivers to make appropriate preparations. We performed discriminant analysis on a placebo data set of over 5,000 patients with Alzheimer's disease in order to create a model that predicts the rate of cognitive decline in Alzheimer's disease from simple demographic data and the baseline score on the cognitive subscale of the Alzheimer's Disease Assessment Scale or the Mini Mental State Examination. This model has 96-97% sensitivity and 92-93% specificity. The potential benefits of this model argue for its validation in a prospective study. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14512724     DOI: 10.1159/000072813

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

1.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

2.  Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.

Authors:  Michelle M Mielke; Norman J Haughey; Veera Venkata Ratnam Bandaru; Danielle D Weinberg; Eveleen Darby; Noman Zaidi; Valory Pavlik; Rachelle S Doody; Constantine G Lyketsos
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.